The residual H5N1 antibody results and epidemiological characteristics involved on the volunteer group in Ninh Hoa distric
DOI:
https://doi.org/10.56086/jcvb.v1i.3Keywords:
Residual H5N1 antibodies, IVACFLU-A/H5N1 vaccineAbstract
Non-controlled longitudinal study were carry on 185 subjects who received 2 doses of 15µg IVACFLU-A / H5N1 vaccine 21 days apart to determine persistent of antibody-H5N1 and some Epidemiological characteristics involved, the results showed that: 18 months after IVACFLU-A / H5N1 vaccination, the rate of antibody protection (titre ≥ 1/40) still reached 61.6%; GMTs of the injection group reached 49.2. No statically differences on age, gender and epidemiological characteristics related persistent of anti-H5N1 antibody after vaccination. The research is still ongoing until 36 months after vaccination.